Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas

Genome Medicine
Alexandra R BuckleyNicholas J Schork

Abstract

Cancer susceptibility germline variants generally require somatic alteration of the remaining allele to drive oncogenesis and, in some cases, tumor mutational profiles. Whether combined germline and somatic bi-allelic alterations are universally required for germline variation to influence tumor mutational profile is unclear. Here, we performed an exome-wide analysis of the frequency and functional effect of bi-allelic alterations in The Cancer Genome Atlas (TCGA). We integrated germline variant, somatic mutation, somatic methylation, and somatic copy number loss data from 7790 individuals from TCGA to identify germline and somatic bi-allelic alterations in all coding genes. We used linear models to test for association between mono- and bi-allelic alterations and somatic microsatellite instability (MSI) and somatic mutational signatures. We discovered significant enrichment of bi-allelic alterations in mismatch repair (MMR) genes and identified six bi-allelic carriers with elevated MSI, consistent with Lynch syndrome. In contrast, we find little evidence of an effect of mono-allelic germline variation on MSI. Using MSI burden and bi-allelic alteration status, we reclassify two variants of unknown significance in MSH6 as potent...Continue Reading

References

Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Mar 1, 1953·British Journal of Cancer·C O NORDLING
Jan 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judy E Garber, Kenneth Offit
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Jan 7, 2010·Human Mutation·Mary I Coolbaugh-MurphyMichael J Siciliano
May 21, 2010·Human Molecular Genetics·Nelly BurnichonAnne-Paule Gimenez-Roqueplo
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Oct 5, 2010·PLoS Genetics·Amy M DworkinAmanda Ewart Toland
May 2, 2012·Current Genomics·Cristina BozzaoAlessandro Stella
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium
Mar 9, 2013·Familial Cancer·Bente A Talseth-PalmerRodney J Scott
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Jul 25, 2013·Familial Cancer·John BurnD Tim Bishop
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Sep 28, 2013·Nature Genetics·UNKNOWN Cancer Genome Atlas Research NetworkJoshua M Stuart
Nov 16, 2013·Nucleic Acids Research·Melissa J LandrumDonna R Maglott
Jan 17, 2014·Nature·Nazneen Rahman
Oct 15, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hany AriffinChang S Chan
Feb 13, 2015·Nature Reviews. Cancer·Henry T LynchMegan P Hitchins
Feb 25, 2015·Nature Reviews. Cancer·Laurence H PearlFrances M G Pearl
Feb 28, 2015·GigaScience·Christopher C ChangJames J Lee
Mar 31, 2015·Nature Methods·Aaron M NewmanAsh A Alizadeh
Oct 21, 2015·Biopreservation and Biobanking·Latarsha J Carithers, Helen M Moore
Dec 18, 2015·Nucleic Acids Research·Robert D FinnAlex Bateman
May 3, 2016·Nature·Serena Nik-ZainalMichael R Stratton
Jun 9, 2016·Genome Biology·William McLarenFiona Cunningham
Aug 19, 2016·Nature·Monkol LekUNKNOWN Exome Aggregation Consortium
Sep 23, 2016·The New England Journal of Medicine·Robert L GrossmanLouis M Staudt
Nov 1, 2016·Nature Medicine·Ronald J HauseStephen J Salipante
Dec 3, 2016·Nucleic Acids Research·Simon A ForbesPeter J Campbell
Feb 7, 2017·Cancer Cell·Lauren FishbeinMatthew D Wilkerson
Feb 12, 2017·Cancer Discovery·Hannah CarterTrey Ideker
Mar 25, 2017·Science·Cristian TomasettiBert Vogelstein
Jun 7, 2017·Nature Communications·Isidro Cortes-CirianoPeter J Park

❮ Previous
Next ❯

Software Mentioned

RNASeQCv1
PLINK
DeconstructSigs
Genomic Data Commons ( GDC
Broad Firehose
COSMIC
mpileup
GATK
ANNOVAR
GSEA

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.